Vyepti Infusion
Eptinezumab-jjmr
Vyepti® (eptinezumab-jjmr) is a prescription medication for the preventive treatment of migraines.
As a targeted therapy, Vyepti has been formulated to reduce the frequency, severity, and duration of migraine episodes through a consistent and long-acting treatment approach. Safe and effective for adults, Vyepti is not currently approved or indicated for use in pediatric patients, as its safety and efficacy have not been established in individuals under 18 years of age.
As with all prescription medications, providers should consider individual patient profiles and clinical histories when determining if Vyepti (eptinezumab-jjmr) is an appropriate treatment option.
To see drug manufacturer details, click here. Helpful FAQs about Vyepti infusions are featured below.
Indication:
Preventive treatment of migraine in adults
Vyepti Infusion Duration:
Frequency:
Every 3 months
Vyepti Migraine Infusions: FAQs
If you have questions about Vyepti infusions for migraine prevention, you're not alone.
Providers and patients considering Vyepti infusion often want a full understanding of:
How this treatment works
What to expect during a Vyepti migraine infusion
Whether it’s the right option for them (or their patients).
The following FAQs cover the most common questions about eptinezumab-jjmr dosing, safety, efficacy, and more.
If you have questions about Vyepti infusions not answered below, please contact the LUX Infusion team for answers specific to you and your circumstances
-
Migraine infusion therapy involves delivering medication directly into the bloodstream through an intravenous (IV) line. This method allows for:
Fast, consistent absorption
Precise dose control
100% bioavailability, meaning the full dose enters the system without being altered by digestion or other factors
Preventive treatment and, in turn, relief from frequent, debilitating migraines.
For preventive care, medications like Vyepti (eptinezumab-jjmr) are administered via a short infusion every few months to help reduce the incidence, intensity, and duration of migraine attacks.
Generally, Vyepti IV therapy is well-tolerated and administered in a comfortable clinical setting under the supervision of trained medical staff.
-
A Vyepti infusion is an IV administration of eptinezumab-jjmr to prevent migraines in adults. Eptinezumab-jjmr, the generic form of Vyepti, is a monoclonal antibody that:
Targets the calcitonin gene-related peptide (CGRP), a protein associated with migraine pathophysiology
Inhibits CGRP activity, thereby preventing the cascade of events that can lead to migraine attacks
Can reduce the incidence and intensity of migraines.
Vyepti is available in 100 mg and 300 mg doses, with the appropriate dosage determined based on patient needs and response to therapy.
As with any medical treatment, Vyepti infusion may not be suitable for every patient. However, for many patients, the benefits of Vyepti migraine infusion far outweigh any potential risks.
-
The Vyepti infusion process involves a couple of key steps and considerations:
Infusion duration: For the Vyepti migraine infusion alone, it takes approximately 30 minutes to intravenously administer the medication, regardless of whether it’s the 100 mg or 300 mg dose.
Total appointment time: While the Vyepti infusion itself lasts about 30 minutes, the total time spent at an infusion center or provider’s facility may be slightly longer. That’s because additional time is needed for pre-infusion preparations, such as setting up the IV line, and post-infusion procedures, including monitoring and flushing the IV line.
After the Vyepti IV treatment is complete, patients can typically resume their daily activities without any downtime.
-
Vyepti infusions are administered once every 12 weeks or three months as part of a regular treatment schedule. That works out to four Vyepti infusions per year.
Sticking to a schedule for Vyepti infusion for migraines is crucial to sustained prevention. Consequently, many providers recommend that patients book their next Vyepti infusion appointment before leaving a facility.
While that can simplify consistent treatment, it’s important to point out that you may not always be at home or by your go-to infusion center.
If you’re traveling when you need a Vyepti infusion, here’s what you can do when:
You’re visiting Alaska: Consider LUX Infusion for Vyepti infusion in Anchorage, Palmer, and Fairbanks. We routinely administer Vyepti IV treatment to travelers visiting Alaska throughout the year.
You’re anywhere outside of Alaska: You can use this Vyepti infusion locator to find the closest provider near you.
-
Yes, Vyepti infusions are generally covered under Medicare Part B when:
Deemed medically necessary
Administered intravenously by a healthcare professional.
When it comes to Vyepti Medicare coverage, please be aware that:
There may be some out-of-pocket costs for Vyepti infusions, even after deductibles have been met.
Supplemental insurance may cover some or all out-of-pocket costs.
Some coverage requires prior authorization for Vyepti infusions.
To help you with the complexities of coverage and costs, LUX Infusions has dedicated patient navigators, who are ready to guide you through financial assistance programs, reimbursements, and more, so you can make informed decisions with experienced support by your side.
-
Yes, eptinezumab-jjmr (brand name Vyepti) is classified as a biologic medication.
Biologics are drugs that contain or are derived from living organisms. Specifically, Vyepti is a humanized monoclonal antibody that targets the CGRP ligand, which plays a significant role in the pathophysiology of migraines.
-
LUX Infusion is a trusted provider of Vyepti infusions in Alaska, with luxury infusion clinics conveniently based in Anchorage, Fairbanks, and Palmer.
To find out more about scheduling Vyepti infusions at LUX, simply contact us.